Reports

Drug name	NICE TAs	Comments
Aripiprazole tablets	TA213 - Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years TA292 - Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorder	Supported by ESCA. The GP should be given a rationale for prescribing rather than first line antipsychotics. Approved for use in Tourette's Syndrome.
Arsenic trioxide	TA526 - Arsenic trioxide for treating acute promyelocytic leukaemia	Hospital use only
Artemether with lumefantrine (Riamet®)		Specialist advice only
Artesunate		Specialist advice only
Articaine 40mg in 1ml adrenaline injection		For dental use only
Asfotase alfa		NHSE commissioned
Aspirin 300mg dispersible tablets		Topical analgesia - for gargling
Atezolizumab (Tecentriq®)	TA492 - Atezolizumab for untreated PD-L1-positive locally advanced or metastatic urothelial cancer when cisplatin is unsuitable TA520 - Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapy TA525 - Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy TA333 - Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment TA584 - Atezolizumab in combination for treating metastatic non-squamous non-small-cell lung cancer TA639 - Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancer TA638 - Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer TA666 - Atezolizumab with bevacizumab for treating advanced or unresectable hepatocellular carcinoma TA705 - Atezolizumab monotherapy for untreated advanced non-small-cell lung cancer	Hospital use only
Atogepant (Aquipta®)	NICE TA 973 Atogepant for preventing migrane	Use in accordance with NICE
Atomoxetine		ESCAs and additional advice in relation to age of patient and CCG

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
Next page
Last page

University Hospitals Birmingham NHS Foundation Trust

Medicines Formulary

Reports